Opioid inaccessibility and its human consequences: reports from the field

J Pain Palliat Care Pharmacother. 2010 Sep;24(3):239-43. doi: 10.3109/15360288.2010.501852.

Abstract

Strong opioids such as morphine are rarely accessible in low- and middle-income countries, even for patients with the most severe pain. The three cases reported here from three diverse countries provide examples of the terrible and unnecessary suffering that occurs everyday when this essential, inexpensive, and safe medication is not adequately accessible by patients in pain. The reasons for this lack of accessibility are explored, and ways to resolve the problem are proposed.

Publication types

  • Case Reports

MeSH terms

  • Acquired Immunodeficiency Syndrome / physiopathology
  • Adult
  • Analgesics, Opioid / supply & distribution*
  • Analgesics, Opioid / therapeutic use
  • Developing Countries
  • Dyspnea / drug therapy
  • Fatal Outcome
  • Female
  • Health Services Accessibility*
  • Heroin / therapeutic use
  • Humans
  • Male
  • Middle Aged
  • Morphine / supply & distribution*
  • Morphine / therapeutic use
  • Neoplasm Metastasis
  • Ovarian Neoplasms / pathology
  • Ovarian Neoplasms / physiopathology
  • Pain / drug therapy*
  • Palliative Care*
  • Patient Rights*
  • Prostatic Neoplasms / pathology
  • Prostatic Neoplasms / physiopathology
  • Suicide
  • Terminally Ill

Substances

  • Analgesics, Opioid
  • Heroin
  • Morphine